These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 14675041

  • 1. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
    Ma LJ, Jha S, Ling H, Pozzi A, Ledbetter S, Fogo AB.
    Kidney Int; 2004 Jan; 65(1):106-15. PubMed ID: 14675041
    [Abstract] [Full Text] [Related]

  • 2. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1.
    Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB.
    Kidney Int; 2000 Dec; 58(6):2425-36. PubMed ID: 11115076
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
    Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB.
    Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
    [Abstract] [Full Text] [Related]

  • 4. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M, Burke JF, McGowan TA, Zhu Y, Dunn SR, McCue P, Kanalas J, Sharma K.
    Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
    [Abstract] [Full Text] [Related]

  • 5. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
    Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE, Fogo AB.
    Kidney Int; 2000 Sep; 58(3):1219-27. PubMed ID: 10972684
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
    Krag S, Danielsen CC, Carmeliet P, Nyengaard J, Wogensen L.
    Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A.
    Ann Acad Med Stetin; 1999 Dec; Suppl 52():1-93. PubMed ID: 10589103
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-β1 levels.
    Zhao J, Cheng Q, Ye P, Yang G, Liu S, Ao Q, Liu Y, Hu Y.
    Exp Gerontol; 2016 Feb; 74():37-42. PubMed ID: 26680767
    [Abstract] [Full Text] [Related]

  • 13. [Effects of Shensu II Recipe on the expressions of transforming growth factor-beta1, and plasminogen activator inhibitor-1 in the focal segmental glomerulosclerosis rats].
    Dou YT, Yang HT, Cao SL.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Nov; 31(11):1531-7. PubMed ID: 22303720
    [Abstract] [Full Text] [Related]

  • 14. Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis.
    Fukui M, Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Koide H.
    J Lab Clin Med; 1993 Feb; 121(2):224-34. PubMed ID: 8094426
    [Abstract] [Full Text] [Related]

  • 15. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB.
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis.
    Grygielko ET, Martin WM, Tweed C, Thornton P, Harling J, Brooks DP, Laping NJ.
    J Pharmacol Exp Ther; 2005 Jun; 313(3):943-51. PubMed ID: 15769863
    [Abstract] [Full Text] [Related]

  • 18. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
    Peters H, Daig U, Martini S, Rückert M, Schäper F, Liefeldt L, Krämer S, Neumayer HH.
    Kidney Int; 2003 Aug; 64(2):509-18. PubMed ID: 12846746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.